HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone844-406-1852
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date10/24/2019 (Confirmed)
OptionableOptionable
HEXO (NASDAQ:HEXO) Frequently Asked Questions
What is HEXO's stock symbol?
HEXO trades on the NASDAQ under the ticker symbol "HEXO."
When is HEXO's next earnings date?
How can I listen to HEXO's earnings call?
HEXO will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has HEXO issued on next quarter's earnings?
HEXO issued an update on its FY 2019 earnings guidance on Thursday, October, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $46.5-48.5 million.
What price target have analysts set for HEXO?
10 Wall Street analysts have issued 12-month price objectives for HEXO's stock. Their forecasts range from $3.00 to $12.00. On average, they expect HEXO's stock price to reach $7.45 in the next year. This suggests a possible upside of 165.2% from the stock's current price. View Analyst Price Targets for HEXO.
What is the consensus analysts' recommendation for HEXO?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HEXO.
Has HEXO been receiving favorable news coverage?
Media stories about HEXO stock have trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. HEXO earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for HEXO.
Who are some of HEXO's key competitors?
Some companies that are related to HEXO include Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), OrganiGram (OGI), Next Science (NXS), HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Supreme Cannabis (FIRE), Benchmark (BMK), ICC Labs (ICC), Flowr (FLWR), Shield Therapeutics (STX), Amryt Pharma (AMYT), CannTrust (TRST) and Althea Group (AGH).
What other stocks do shareholders of HEXO own?
Who are HEXO's key executives?
HEXO's management team includes the folowing people:
- Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)
- Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)
- Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)
- Mr. James McMillan, VP of Bus. Devel. (Age 51)
- Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility
Who are HEXO's major shareholders?
HEXO's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include CLARET ASSET MANAGEMENT Corp (0.02%).
Which major investors are buying HEXO stock?
HEXO stock was bought by a variety of institutional investors in the last quarter, including CLARET ASSET MANAGEMENT Corp.
How do I buy shares of HEXO?
Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is HEXO's stock price today?
One share of HEXO stock can currently be purchased for approximately $2.81.
How big of a company is HEXO?
What is HEXO's official website?
How can I contact HEXO?
The company can be reached via phone at 844-406-1852.
MarketBeat Community Rating for HEXO (NASDAQ HEXO)
MarketBeat's community ratings are surveys of what our community members think about HEXO and other stocks. Vote "Outperform" if you believe HEXO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HEXO will underperform the S&P 500 over the long term. You may vote once every thirty days.
